Chiba S - Search Results

1

Development of atherosclerosis in osteopontin transgenic mice.

Chiba S, Okamoto H, Kon S, Kimura C, Murakami M, Inobe M, Matsui Y, Sugawara T, Shimizu T, Uede T, Kitabatake A. Chiba S, et al. Heart Vessels. 2002 Mar;16(3):111-7. doi: 10.1007/s003800200005. Heart Vessels. 2002. PMID: 12027233

2

Angiotensin II type 1 receptor gene polymorphisms in patients with cardiac hypertrophy.

Ishanov A, Okamoto H, Watanabe M, Yoneya K, Nakagawa I, Kumamoto H, Chiba S, Hata A, Kawaguchi H, Kitabatake A. Ishanov A, et al. Among authors: chiba s. Jpn Heart J. 1998 Jan;39(1):87-96. doi: 10.1536/ihj.39.87. Jpn Heart J. 1998. PMID: 9601485

3

Beneficial effect of myocardial angiogenesis on cardiac remodeling process by amlodipine and MCI-154.

Kumamoto H, Okamoto H, Watanabe M, Onozuka H, Yoneya K, Nakagawa I, Chiba S, Watanabe S, Mikami T, Abe K, Kitabatake A. Kumamoto H, et al. Among authors: chiba s. Am J Physiol. 1999 Apr;276(4):H1117-23. doi: 10.1152/ajpheart.1999.276.4.H1117. Am J Physiol. 1999. PMID: 10199832

4

Blockade of T cell costimulatory signals using adenovirus vectors prevents both the induction and the progression of experimental autoimmune myocarditis.

Matsui Y, Inobe M, Okamoto H, Chiba S, Shimizu T, Kitabatake A, Uede T. Matsui Y, et al. Among authors: chiba s. J Mol Cell Cardiol. 2002 Mar;34(3):279-95. doi: 10.1006/jmcc.2001.1511. J Mol Cell Cardiol. 2002. PMID: 11945021

5

Long-term combined therapy with an angiotensin type I receptor blocker and an angiotensin converting enzyme inhibitor prolongs survival in dilated cardiomyopathy.

Shimizu T, Okamoto H, Chiba S, Matsui Y, Sugawara T, Onozuka H, Mikami T, Kumamoto H, Kitabatake A. Shimizu T, et al. Among authors: chiba s. Jpn Heart J. 2002 Sep;43(5):531-43. doi: 10.1536/jhj.43.531. Jpn Heart J. 2002. PMID: 12452311 Free article.

6

Altered microvasculature is involved in remodeling processes in cardiomyopathic hamsters.

Shimizu T, Okamoto H, Watanabe M, Kumamoto H, Chiba S, Matsui Y, Sugawara T, Onozuka H, Mikami T, Kitabatake A. Shimizu T, et al. Among authors: chiba s. Jpn Heart J. 2003 Jan;44(1):111-26. doi: 10.1536/jhj.44.111. Jpn Heart J. 2003. PMID: 12622443 Free article.

7

VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts.

Shimizu T, Okamoto H, Chiba S, Matsui Y, Sugawara T, Akino M, Nan J, Kumamoto H, Onozuka H, Mikami T, Kitabatake A. Shimizu T, et al. Among authors: chiba s. Cardiovasc Res. 2003 Apr 1;58(1):203-12. doi: 10.1016/s0008-6363(02)00843-x. Cardiovasc Res. 2003. PMID: 12667963

8

[Osteopontin can induce fatty streak].

Chiba S. Chiba S. Hokkaido Igaku Zasshi. 2003 Mar;78(2):147-52. Hokkaido Igaku Zasshi. 2003. PMID: 12704857 Japanese. No abstract available.

9

A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.

Jia N, Okamoto H, Shimizu T, Chiba S, Matsui Y, Sugawara T, Akino M, Kitabatake A. Jia N, et al. Among authors: chiba s. Hypertens Res. 2003 Sep;26(9):737-42. doi: 10.1291/hypres.26.737. Hypertens Res. 2003. PMID: 14620930 Free article.

10

[Osteopontin can induce cardiopulmonary lesions consisting of macrophage infiltration and granuloma formation].

Chiba S. Chiba S. Hokkaido Igaku Zasshi. 2002 Mar;77(2):193-205. Hokkaido Igaku Zasshi. 2002. PMID: 11968855 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,687 results

Search Page

Filters